An Illustration of the Potential Health and Economic Benefits of Combating Antibiotic-Resistant Gonorrhea

Sexually Transmitted Diseases
Harrell W ChessonHillard S Weinstock

Abstract

Preventing the emergence of ceftriaxone-resistant Neisseria gonorrhoeae can potentially avert hundreds of millions of dollars in direct medical costs of gonorrhea and gonorrhea-attributable HIV infections. In the illustrative scenario we examined, emerging ceftriaxone resistance could lead to 1.2 million additional N. gonorrhoeae infections within 10 years, costing $378.2 million.

References

Jun 27, 2002·Sexually Transmitted Infections·K M E Turner, G P Garnett
Oct 17, 2006·PLoS Computational Biology·Andreas HandelRustom Antia
May 27, 2008·Cost Effectiveness and Resource Allocation : C/E·Harrell W ChessonKathryn Koski
Mar 3, 2011·Current Infectious Disease Reports·Robert D KirkcaldyDeborah Dowell
Dec 16, 2011·Sexually Transmitted Infections·Christina H ChanDavid N Fisman
Feb 14, 2013·Sexually Transmitted Diseases·Catherine Lindsey SatterwhiteHillard Weinstock
Feb 14, 2013·Sexually Transmitted Diseases·Kwame Owusu-EduseiCharlotte K Kent
Sep 21, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Paul G FarnhamStephanie L Sansom
Mar 25, 2014·Emerging Infectious Diseases·Harrell W ChessonHillard S Weinstock
Sep 4, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan E VolkC Bradley Hare
May 20, 2016·PLoS Pathogens·Stephanie M FingerhuthChristian L Althaus
Jul 19, 2016·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team

❮ Previous
Next ❯

Citations

Feb 27, 2020·International Journal of Environmental Research and Public Health·Tingting Jiang, Xiang-Sheng Chen
Jul 10, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xiang-Sheng ChenXin-Yu Li
Oct 13, 2020·Sexually Transmitted Diseases·Salvatore CurrentiSushma Peravali
Jul 7, 2021·Expert Review of Molecular Diagnostics·Barbara Van Der Pol, Charlotte A Gaydos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Medical Clinics of North America
P F Sparling
International Journal of Dermatology
V N Sehgal, G Srivastava
Emerging Infectious Diseases
Makoto OhnishiJo Kitawaki
Nederlands tijdschrift voor geneeskunde
J J van EverdingenE Stolz
Medical & Biological Illustration
R J Lunnon
© 2022 Meta ULC. All rights reserved